Axon Enterprise
AXON
#539
Rank
$43.49 B
Marketcap
$551.22
Share price
0.05%
Change (1 day)
-14.22%
Change (1 year)

Axon Enterprise (AXON) - Cash on Hand

Cash on Hand as of September 2025 : $2.44 Billion USD

According to Axon Enterprise 's latest financial reports the company has $2.44 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Axon Enterprise - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.98 B-25.31%
2023-12-31$1.32 B35.48%
2022-12-31$0.97 B120.01%
2021-12-31$0.44 B-21.17%
2020-12-31$0.56 B60.2%
2019-12-31$0.35 B0.38%
2018-12-31$0.34 B326.34%
2017-12-31$81.96 M-7.97%
2016-12-31$89.06 M-18.87%
2015-12-31$0.10 B35.3%
2014-12-31$81.14 M57.95%
2013-12-31$51.37 M35.88%
2012-12-31$37.8 M43.16%
2011-12-31$26.4 M-38.13%
2010-12-31$42.68 M-6.2%
2009-12-31$45.5 M-7.85%
2008-12-31$49.37 M-3.75%
2007-12-31$51.3 M129.73%
2006-12-31$22.33 M36.56%
2005-12-31$16.35 M-48.83%
2004-12-31$31.95 M101.27%
2003-12-31$15.87 M343.91%
2002-12-31$3.57 M-36.54%
2001-12-31$5.63 M2630.56%
2000-12-31$0.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
XBiotech
XBIT
$0.14 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$29.61 M-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$0.98 B-59.57%๐Ÿ‡บ๐Ÿ‡ธ USA